If you got Medicare only because of kidney failure, your coverage is set to end three years after your transplant. That includes the anti-rejection drugs that keep your new kidney working. So does Medicare cover anti-rejection drugs after a transplant? For kidney transplant patients in that spot, yes, but you have to opt in. Since January 2023, a benefit called Part B-ID lets you hold onto that drug coverage alone.
In This Guide
- Key Takeaways
- Does Medicare Cover Anti-Rejection Drugs After a Transplant?
- Who the Immunosuppressive Drug Benefit Helps
- What the Immunosuppressive Drug Benefit Costs in 2026
- When You Can't Use the Immunosuppressive Drug Benefit
- How to Keep Medicare Covering Anti-Rejection Drugs After a Transplant
- Frequently Asked Questions
- Learn More
Does Medicare Cover Anti-Rejection Drugs After a Transplant?
Yes, and for most transplant patients that coverage just keeps running through Part B the way it always has. The wrinkle is for one specific group: people who qualified for Medicare only because their kidneys failed.
If that's you, your Medicare wasn't permanent. It was tied to your kidney disease, and it ends 36 months after a successful kidney transplant.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease When it ends, so does coverage for the immunosuppressive drugs you have to take for the life of the transplant. For years, that left transplant recipients staring down full-price anti-rejection medication with no Medicare behind it.
Congress fixed that gap. The Centers for Medicare & Medicaid Services (CMS) now runs the Part B Immunosuppressive Drug benefit, usually shortened to Part B-ID. Effective January 2023, it lets you keep Medicare coverage of your immunosuppressive drugs after your regular Medicare ends.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease It's narrow on purpose, and it comes with its own premium, but it closes the door that used to slam shut at month 36.
Who the Immunosuppressive Drug Benefit Helps
This benefit isn't for everyone with a transplant. It's aimed squarely at people whose only tie to Medicare was ESRD. Three things have to line up.
First, you have Medicare only because of End-Stage Renal Disease. If you also qualify another way, say you're 65 or older, or you get Medicare through a disability, your Part B doesn't expire at 36 months and you don't need this benefit. Second, your full Medicare coverage is ending (or already ended) 36 months after a successful kidney transplant. Third, you don't have and don't expect to get certain other coverage that pays for immunosuppressive drugs.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease
One thing to be clear-eyed about: Part B-ID covers your immunosuppressive drugs and no other items or services.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease It is not a stand-in for full health insurance. It won't pay for a doctor visit, a hospital stay, or any other prescription. If you go this route, you'll still want a real plan for the rest of your health care, whether that's a marketplace plan, Medicaid, or coverage through a job. Part B-ID just makes sure the one set of drugs your transplant depends on stays covered.
What the Immunosuppressive Drug Benefit Costs in 2026
Here's how the money side works, and it's worth reading closely, because the numbers are not the same as regular Part B.
The Part B-ID premium is $121.60 a month in 2026, and it runs higher for people who owe an income-related adjustment.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease That's actually lower than the standard Part B premium of $202.90, which makes sense: you're paying for drug coverage alone, not the full Part B package.Centers for Medicare & Medicaid Services. (2026). 2026 Medicare Parts A & B Premiums and Deductibles. cms.gov. Retrieved Jun 22, 2026, from https://www.cms.gov/newsroom/fact-sheets/2026-medicare-parts-b-premiums-deductibles
On top of the premium, there's an annual deductible of $283 in 2026, the same figure as the standard Part B deductible.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease Once you've met it, you pay 20% of the Medicare-approved amount for your immunosuppressive drugs and Medicare picks up the other 80%.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease
So a rough shape of your year: the monthly premium, the deductible once, and then a fifth of your drug costs after that.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease It's real money. But set against paying the full sticker price for anti-rejection drugs with zero coverage, it's a very different picture.
When You Can't Use the Immunosuppressive Drug Benefit
Part B-ID has a coverage test built into it. You can't elect it if you have, or expect to get, certain other coverage that already pays for immunosuppressive drugs.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease The kinds of coverage that count include a group or individual health plan, TRICARE, and Medicaid that covers immunosuppressive drugs.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease
The logic is that this benefit fills a gap, not doubles up on coverage you already have. So if you've got a job-based plan or a spouse's plan that covers your anti-rejection medication, or you're enrolled in Medicaid that does, that's your coverage, and Part B-ID isn't meant to sit on top of it.
Where it gets easy to trip up is timing. Coverage situations change, jobs end, a plan drops a drug. If your other coverage falls away, that can be exactly when Part B-ID becomes the right move. It's worth checking your standing with Social Security whenever your insurance picture shifts, rather than assuming the door is closed for good.
How to Keep Medicare Covering Anti-Rejection Drugs After a Transplant
The one thing to know is that Part B-ID is not automatic. Your regular Medicare doesn't quietly convert to it when the 36 months run out. You have to enroll, and you do that through the Social Security Administration.Centers for Medicare & Medicaid Services. (n.d.). End-Stage Renal Disease (ESRD). medicare.gov. Retrieved Jul 17, 2026, from https://www.medicare.gov/basics/end-stage-renal-disease
The smart timing is to act before your full Medicare ends, so there's no gap where you're paying out of pocket for drugs. Contact Social Security as you approach the 36-month mark, or as soon as you know your coverage is ending, and ask specifically about the immunosuppressive drug benefit. If your situation is tangled, a transplant center's social worker or financial counselor has usually walked other patients through this and can point you to the right forms.
Frequently Asked Questions
Does Medicare cover anti-rejection drugs after a kidney transplant?
Yes. For most people, Part B keeps covering them as usual. If you had Medicare only because of End-Stage Renal Disease, your coverage ends 36 months after a successful transplant, but you can elect the Part B Immunosuppressive Drug benefit to keep coverage of those drugs going.
What is Part B-ID?
It's the Part B Immunosuppressive Drug benefit, a limited Medicare enrollment that started in January 2023. It covers immunosuppressive (anti-rejection) drugs only, for certain kidney transplant recipients whose full Medicare would otherwise end at 36 months.
How much does the immunosuppressive drug benefit cost in 2026?
The monthly premium is $121.60 in 2026 (higher if you owe an income-related adjustment). There's a $283 annual deductible, and after that you pay 20% of the Medicare-approved amount for your immunosuppressive drugs.
Does Part B-ID replace my full Medicare?
No, and this is the piece people miss: it's a drug-only benefit, so you're left uncovered for doctor visits, hospital stays, and every other prescription. Before your full Medicare ends, line up a plan for the rest of your care too, whether that's a marketplace plan, Medicaid, or job-based coverage.
What if I have other insurance?
You can't elect Part B-ID if you have, or expect to get, certain other coverage that pays for immunosuppressive drugs, such as a group or individual health plan, TRICARE, or Medicaid that covers those drugs. If that coverage later ends, Part B-ID may become an option.
Learn More
Find personalized help figuring out whether the immunosuppressive drug benefit fits your situation at brevy.com.
The information on Brevy.com is for educational purposes only and is not a substitute for professional legal, financial, or medical advice. Rules vary by state and program and change frequently. Always verify with the relevant agency or a qualified professional. Brevy is not a law firm, financial advisor, or healthcare provider.